查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
腱鞘炎治療市場 - 全球行業規模,份額,趨勢,機會,預測，2018-2028 年，按治療,按症狀,按地區,競爭
市場調查報告書
商品編碼
1255209

腱鞘炎治療市場 - 全球行業規模,份額,趨勢,機會,預測，2018-2028 年，按治療,按症狀,按地區,競爭

Tendonitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Therapy, By Condition, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球肌腱炎治療市場預計在預測期內將出現顯著增長。

這是由於骨質疏鬆症和骨質疏鬆導致的老齡化社會中骨相關損傷的發生率不斷增加。 此外，對最佳和最低成本治療的需求不斷增加，以及對關節操作和物理治療等新療法的認識不斷提高，將顯著增加世界各個地區對肌腱炎治療市場的需求。。 此外，全球範圍內用於治療骨病的醫療保健基礎設施不斷增加，預計也將進一步增加對肌腱炎治療的需求，並推動市場增長到 2027 年。 保持健康生活方式的意識增強，以及人們對體育活動的渴望，預計將在預測期內進一步推動肌腱炎治療市場的增長。 此外，肌肉和關節創傷和過度使用等運動相關傷害的增加,康復不足以及訓練課程不平衡預計將增加對肌腱炎治療的需求並推動市場增長。 根據美國國家安全委員會 (NSC) 的數據，到 2021 年，運動器材將造成近 409,000 起傷害，是體育和娛樂類中最多的。

運動相關傷害增加

導致運動損傷的體育相關活動激增，預計在預測期內將產生有利可圖的增長。 運動損傷會導致軟組織損傷，這可能是全球市場的主要驅動力。 越來越多的人選擇體育作為職業或愛好，並在體育領域尋找工作機會。 根據弗吉尼亞大學和杜克大學運動醫學專家的一項研究，跟腱病影響了 40% 到 50% 的競技跑步者。 腱鞘炎在人群中日益流行，每 100,000 人中有 5-10 人受到影響，預計在預測期內將提振市場。 同樣，越來越多尋求物理治療和微創手術的患者預計將在預測期內推動市場增長。

人口老齡化

許多類型的慢性病影響著世界各地的人們。 在腱鞘炎中，連接肌肉和骨骼的粗纖維索被感染。 主要在老齡化社會中肌腱炎病例的增加正在增加對肌腱炎治療的需求，預計這將在預測期內推動市場增長。 據估計，全世界每年平均報告有 3200 萬例肌腱損傷。 因此，許多事故受傷的患者要求物理治療,非處方止痛藥和外科手術，進一步推動了預測期內的市場增長。 由於偏心加強是肌腱疾病的主要治療方法，物理療法將成為治療肌腱炎的首選，在預測期內推動市場增長。 這些是預測期內全球肌腱炎治療市場增長的主要驅動力。 美國每年大約有 3000 萬兒童和青少年參加某種形式的有組織的運動，每年發生超過 350 萬例與運動相關的傷害，這推動了對肌腱炎治療的需求。 根據美國國家安全委員會 (NSC) 的數據，到 2021 年，運動器材將造成近 409,000 起傷害，是體育和娛樂類中最多的。

近期發展

  • InGeneron Inc. 是一家臨床階段的細胞療法和再生醫學公司，它宣布 adult 於 2021 年 7 月發布了世界上第一個對肌腱修復進行全面免疫組織化學評估的結果。

可用的自定義

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家）進行深入分析和概況分析。

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素,挑戰和趨勢概述

第 4 章 VOC（客戶之聲）

  • 腱鞘炎患病率（按年齡組劃分）
  • 肌腱炎患病率（按性別分類）
  • 腱鞘炎患病率（按地區）
  • 常見的肌腱炎症狀

第 5 章腱鞘炎治療的全球市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型（治療方法/手術方法）
    • 根據症狀（網球肘,高爾夫球肘,投手肘,跳投膝等）
    • 按地區
    • 按公司分類（2022 年）
  • 市場地圖
    • 按類型
    • 按條件
    • 按地區

第六章北美腱鞘炎治療市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型（治療方法/手術方法）
    • 根據症狀（網球肘,高爾夫球肘,投手肘,跳投膝等）
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 加拿大
    • 墨西哥

第七章歐洲腱鞘炎治療市場前景

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型（治療方法/手術方法）
    • 根據症狀（網球肘,高爾夫球肘,投手肘,跳投膝等）
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第八章亞太地區腱鞘炎治療市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型（治療方法/手術方法）
    • 根據症狀（網球肘,高爾夫球肘,投手肘,跳投膝等）
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章：南美腱鞘炎治療市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型（治療方法/手術方法）
    • 根據症狀（網球肘,高爾夫球肘,投手肘,跳投膝等）
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章中東和非洲肌腱炎治療市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型（治療方法/手術方法）
    • 通過療法（冷療法,物理療法,衝擊波療法）
    • 根據症狀（網球肘,高爾夫球肘,投手肘,跳投膝等）
    • 按國家
  • MEA：國家分析
    • 南非肌腱炎治療市場前景
      • 市場規模和預測
        • 按金額
      • 市場份額和預測
        • 按類型
        • 按條件
    • 沙特阿拉伯肌腱炎治療市場前景
      • 市場規模和預測
        • 按金額
      • 市場份額和預測
        • 按類型
        • 按條件
    • 阿聯酋治療腱鞘炎的市場前景
      • 市場規模和預測
        • 按金額
      • 市場份額和預測
        • 按類型
        • 按條件

第 11 章市場動態

  • 主持人
  • 任務

第12章市場趨勢與發展

第 13 章全球腱鞘炎治療市場 SWOT 分析

第 14 章波特的五力分析

第15章競爭格局

  • Merck and Co. Inc.
  • Bayer AG
  • AstraZeneca Plc.
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Abbott Laboratories, Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Almatica Pharma, Inc.

第 16 章戰略建議

簡介目錄
Product Code: 14332

Global Tendonitis Treatment Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the increasing incidence of bone-related injuries among the aging population due to osteoporosis or weak bone. Additionally, the growing demand for the best treatment with a low cost, along with increasing awareness about new therapies such as joint manipulation and physical therapy, will significantly increase the demand for the tendonitis treatment market across different parts of the globe. Additionally, the growing improvement of healthcare infrastructure for the treatment of bone disorders across the globe is further expected to increase the demand for tendonitis treatment, thereby fuelling market growth through 2027. Besides growing awareness about maintaining a healthy lifestyle, people are looking for sports activities which will further be expected to support the tendonitis treatment market growth during the forecast period. Furthermore, an increased number of sport-related injuries due to either trauma or overuse of muscles or joints, improper rehabilitation, and imbalanced training sessions are further expected to increase the demand for tendonitis treatment, thereby supporting market growth. According to the National Safety Council (NSC), in 2021, exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation.

Increased Number of Sport-Related Injuries

The rapid increase in sport-related activities causing sport-related injuries is expected to create lucrative growth during the forecast period. Sports injuries can cause soft tissue injuries, which can be a major market driver across the globe. The number of people choosing sports as their career or hobby and getting work opportunities in the field of sports has increased. Achilles tendinopathy affects 40% to 50% of competitive runners, according to a study by sports medicine experts from the University of Virginia and Duke University. Tendonitis is becoming more common day by day in the population, and 5-10 cases per 100,000 population get affected, which is expected to boost the market during the forecast period. Similarly, the number of patients are demanding physical therapy and minimally invasive surgeries, which will propel the market growth during the forecast period.

Stryker has launched the Citrelock Tendon Fixation Device system at the American Orthopaedic Foot and Ankle Society (AOFAS) annual meeting, which was held from 22-25 September 2021 in Charlotte, North Carolina, US, and designed to enable fixation without causing damage to the tendon during placement.

Growing Aging Population

Different types of chronic disorders are affecting people across the globe. In Tendonitis, a thick fibrous cord that connects muscle and bone becomes infected. The growing cases of Tendonitis, majorly among the aging population, are expected to enhance the demand for tendonitis treatment and boost the market growth during the forecast period. There are an estimated 32.0 million tendon injuries reported each year on average across the globe. So, most of the patients who are injured due to accidents demand physical therapy, over-the-counter pain relievers, and surgical procedures, which will further propel the market growth during the forecast period. Eccentric strengthening is the main treatment for tendon disorders, so physical therapy is the first line of treatment for tendonitis, which will boost the market growth during the forecast period. These are the major factor in the growth of the global Tendonitis Treatment Market in the forecast period. Every year in the U.S., about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries each year due to sports injuries will enhance the demand for tendonitis treatment. According to the National Safety Council (NSC), in 2021, exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation.

Market Segmentation

The global tendonitis treatment market can be segmented by therapy, condition, and by region. Based on therapy, the market can be divided into Therapy and Surgery. Based on the condition, the market can be differentiated into Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global tendonitis treatment market on account of the growing demand for advanced technology for the better treatment of tendonitis injuries in the country. As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S.

Market Players

Merck and Co. Inc., Bayer AG, AstraZeneca Plc., Boehringer Ingelheim Pharmaceuticals, Inc., Abbott Laboratories, Inc., Pfizer, Inc., GlaxoSmithKline PLC, Almatica Pharma, Inc. are some of the leading players operating in the Global Tendonitis Treatment Market.

Recent Developments

  • Clinical-stage cell therapy and regenerative medicine company InGeneron Inc. announced in July 2021 that it had published results of the world's first comprehensive immunohistochemical evaluation of adult tendon repair following local injection of fresh, uncultured and undamaged autologous cells from adipose tissue (UA-ADRCs).

Report Scope

In this report, the global tendonitis treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Tendonitis Treatment Market, By Therapy:

  • Therapy
  • Surgery

Tendonitis Treatment Market, By Condition:

  • Tennis Elbow
  • Golfer's Elbow
  • Pitcher's Elbow
  • Jumper's Knee
  • Others

Tendonitis Treatment Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tendonitis Treatment Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

  • 4.1. Prevalence of Tendonitis, By Age Group
  • 4.2. Prevalence of Tendonitis, By Gender
  • 4.3. Prevalence of Tendonitis, By Region
  • 4.4. Commonly Observed Tendonitis Conditions

5. Global Tendonitis Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Therapy v/s Surgery)
      • 5.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
    • 5.2.2. By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By Condition
    • 5.3.3. By Region

6. North America Tendonitis Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Therapy v/s Surgery)
      • 6.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
    • 6.2.2. By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Tendonitis Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Condition
    • 6.3.2. Canada Tendonitis Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Condition
    • 6.3.3. Mexico Tendonitis Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Condition

7. Europe Tendonitis Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Therapy v/s Surgery)
      • 7.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
    • 7.2.2. By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Tendonitis Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Condition
    • 7.3.2. Germany Tendonitis Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Condition
    • 7.3.3. United Kingdom Tendonitis Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Condition
    • 7.3.4. Italy Tendonitis Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Condition
    • 7.3.5. Spain Tendonitis Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Condition

8. Asia-Pacific Tendonitis Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Therapy v/s Surgery)
      • 8.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
    • 8.2.2. By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Tendonitis Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Condition
    • 8.3.2. India Tendonitis Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Condition
    • 8.3.3. Japan Tendonitis Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Condition
    • 8.3.4. South Korea Tendonitis Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Condition
    • 8.3.5. Australia Tendonitis Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Condition

9. South America Tendonitis Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Therapy v/s Surgery)
      • 9.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
    • 9.2.2. By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Tendonitis Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Condition
    • 9.3.2. Argentina Tendonitis Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Condition
    • 9.3.3. Colombia Tendonitis Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Condition

10. Middle East and Africa Tendonitis Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Therapy v/s Surgery)

10.2.1.1.By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)

    • 10.2.2. By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Tendonitis Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Condition
    • 10.3.2. Saudi Arabia Tendonitis Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Condition
    • 10.3.3. UAE Tendonitis Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Condition

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Global Tendonitis Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Merck and Co. Inc.
    • 15.6.2 Bayer AG
    • 15.6.3 AstraZeneca Plc.
    • 15.6.4 Boehringer Ingelheim Pharmaceuticals, Inc.
    • 15.6.5 Abbott Laboratories, Inc.
    • 15.6.6 Pfizer, Inc.
    • 15.6.7 GlaxoSmithKline PLC
    • 15.6.8 Almatica Pharma, Inc.

16. Strategic Recommendations